Pnc Financial Services »

Peregrine Pharmaceuticals shares owned by Pnc Financial Services

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Pnc Financial Services from 13F filings

Historical chart of Pnc Financial Services investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Pnc Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Pnc Financial Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $25k 3.9k 6.50
2023-09-30 $190k 20k 9.44
2023-06-30 $348k 25k 13.97
2023-03-31 $505k 27k 18.76
2022-12-31 $365k 27k 13.77
2022-09-30 $529k 28k 19.11
2022-06-30 $384k 25k 15.25
2022-03-31 $500k 25k 20.38
2021-12-31 $708k 24k 29.19
2021-09-30 $516k 24k 21.56
2021-06-30 $538k 21k 25.67
2021-03-31 $369k 20k 18.24
2019-03-31 $999 143 6.99
2018-12-31 $999 143 6.99
2018-09-30 $999 143 6.99
2018-06-30 $999 143 6.99
2018-03-31 $0 143 0.00